Spectrum Pharma (SPPI) Tops Q2 EPS by 24c

August 9, 2016 4:53 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.05), $0.24 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $30.88 million.

Non-GAAP net loss was $0.5 million, or $(0.01) per basic and diluted share in the comparable period in 2015.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment